Treatment

also known as ZN-c3 clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Open-label, multicenter study to evaluate efficacy and safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma
This study is testing a new medicine, ZN-c3, for women with a type of womb cancer called uterine serous carcinoma that has come back or is still present. It aims to see how well the medicine works and if it has any side effects.
For: recurrent or persistent uterine serous carcinoma
Spain · Italy · France
Authorised (with conditions)Human Pharmacology (Phase I)- Other
PHASE Ib STUDY WITH THE COMBINATION OF LB−100 (PP2A INHIBITOR) AND AZENOSERTIB (WEE1 INHIBITOR) IN PATIENTS WITH METASTATIC COLORECTAL CANCER The COLLEE trial
This study is called COLLEE and is looking at two new medicines, LB-100 and azenosertib, for people with bowel cancer that has spread. We want to see if this combination is safe and how well it works to treat the cancer.
For: Metastatic colorectal cancer
Netherlands